BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2479698)

  • 21. Hyperamylasemia following methyl alcohol intoxication. Source and significance.
    Eckfeldt JH; Kershaw MJ
    Arch Intern Med; 1986 Jan; 146(1):193-4. PubMed ID: 2417569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma.
    Terada T; Nakanuma Y
    Arch Pathol Lab Med; 1993 Feb; 117(2):160-2. PubMed ID: 8381270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung cancer with elevated amylase activity. One observation with study of amylase's isoenzymes (author's transl)].
    Martin M; Minssart P; Sagniez M; Barrier J; Grolleau JY; Bavoux R; Hervouet D
    Nouv Presse Med; 1979 Jun; 8(29):2403-5. PubMed ID: 493026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of amylase-producing lung adenocarcinoma cell line, IMEC-2.
    Yokouchi H; Yamazaki K; Asahina H; Shigemura M; Moriyama T; Takaoka K; Moriya J; Itoh T; Kinoshita I; Dosaka-Akita H; Tsutsumi Y; Nishimura M
    Anticancer Res; 2006; 26(4B):2821-7. PubMed ID: 16886600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperamylasemia and ovarian carcinoma.
    Sandiford JA; Chiknas SG
    Clin Chem; 1979 Jun; 25(6):948-50. PubMed ID: 445830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
    Hayakawa T; Kameya A; Mizuno R; Noda A; Kondo T; Hirabayashi N
    Cancer; 1984 Oct; 54(8):1662-5. PubMed ID: 6206939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary-type hyperamylasemia in primary lung cancer: observation of a possible precursor of the salivary-type isoamylase.
    Maeda M; Otsuki M; Yuu H; Saeki S; Yamasaki T; Baba S
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):123-8. PubMed ID: 6178589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postoperative hyperamylasemia in patients undergoing abdominal surgery: the relationship between serum and peritoneal amylase levels].
    Sato N
    Nihon Geka Gakkai Zasshi; 1992 Aug; 93(8):784-93. PubMed ID: 1279373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative hyperamylasemia, pancreatitis, and primary hyperparathyroidism.
    Watson RG; van Heerden JA; Grant CS; Klee GG
    Surgery; 1984 Dec; 96(6):1151-7. PubMed ID: 6209817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of amylase isoenzyme determination.
    Skrha J; Stĕpán J
    Acta Univ Carol Med Monogr; 1987; 120():1-81. PubMed ID: 2446482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A correlation between clinical pancreatitis and isoenzyme patterns of amylase.
    Weaver DW; Bouwman DL; Walt AJ; Clink D; Resto A; Stephany J
    Surgery; 1982 Oct; 92(4):576-80. PubMed ID: 6181574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of pleural amylase measurement in metastatic mucinous adenocarcinoma.
    Fahim A; Kastelik JA
    J R Coll Physicians Edinb; 2010 Jun; 40(2):119-20. PubMed ID: 21125052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor.
    Frković-Grazio S; Kraljić I; Trnski D; Tarle M
    Anticancer Res; 1994; 14(5B):2151-6. PubMed ID: 7840515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma].
    Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occurrence and nature of hyperamylasemia in chronic alcoholics].
    Pelletier G; Née N; Brivet M; Ponsot P
    Gastroenterol Clin Biol; 1984 Nov; 8(11):792-5. PubMed ID: 6084628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
    Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Two cases of amylase-producing lung cancer].
    Kamio T; Sameshima K; Irie J; Shigematsu K; Kawai K; Tsuchiyama H; Nakano M
    Gan No Rinsho; 1989 May; 35(6):735-40. PubMed ID: 2470931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperamylasemia associated with endometrioid carcinoma of the ovary: case report and immunohistochemical study.
    Yagi C; Miyata J; Hanai J; Ogawa M; Ueda G
    Gynecol Oncol; 1986 Oct; 25(2):250-5. PubMed ID: 2428702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma].
    Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.